Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0
NCT: NCT06725550 · ACTIVE_NOT_RECRUITING
NCT IDNCT06725550
StatusACTIVE_NOT_RECRUITING
Start Date2025-08-25
Completion2027-04-02
SponsorIndiana University (OTHER)
First posted
Last updated
Brief Summary
The proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupuncture analgesia in patients with sickle cell disease.
Frequently Asked Questions
What is Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0?
Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0 is a clinical trial registered under NCT06725550. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06725550?
The current status of NCT06725550 (Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0) is: ACTIVE_NOT_RECRUITING.
When did Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0 start?
Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0 started on 2025-08-25.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.